1. Home
  2. UNCY vs NEUE Comparison

UNCY vs NEUE Comparison

Compare UNCY & NEUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UNCY
  • NEUE
  • Stock Information
  • Founded
  • UNCY 2016
  • NEUE 2015
  • Country
  • UNCY United States
  • NEUE United States
  • Employees
  • UNCY N/A
  • NEUE N/A
  • Industry
  • UNCY Biotechnology: Pharmaceutical Preparations
  • NEUE
  • Sector
  • UNCY Health Care
  • NEUE
  • Exchange
  • UNCY Nasdaq
  • NEUE NYSE
  • Market Cap
  • UNCY 58.7M
  • NEUE 60.7M
  • IPO Year
  • UNCY 2021
  • NEUE 2021
  • Fundamental
  • Price
  • UNCY $0.55
  • NEUE $6.60
  • Analyst Decision
  • UNCY Strong Buy
  • NEUE Hold
  • Analyst Count
  • UNCY 3
  • NEUE 1
  • Target Price
  • UNCY $6.50
  • NEUE $7.00
  • AVG Volume (30 Days)
  • UNCY 925.3K
  • NEUE 46.1K
  • Earning Date
  • UNCY 05-12-2025
  • NEUE 03-20-2025
  • Dividend Yield
  • UNCY N/A
  • NEUE N/A
  • EPS Growth
  • UNCY N/A
  • NEUE N/A
  • EPS
  • UNCY N/A
  • NEUE N/A
  • Revenue
  • UNCY N/A
  • NEUE $936,657,000.00
  • Revenue This Year
  • UNCY N/A
  • NEUE $13.81
  • Revenue Next Year
  • UNCY $888.72
  • NEUE $6.75
  • P/E Ratio
  • UNCY N/A
  • NEUE N/A
  • Revenue Growth
  • UNCY N/A
  • NEUE N/A
  • 52 Week Low
  • UNCY $0.20
  • NEUE $3.79
  • 52 Week High
  • UNCY $1.60
  • NEUE $7.66
  • Technical
  • Relative Strength Index (RSI)
  • UNCY 40.61
  • NEUE 51.59
  • Support Level
  • UNCY $0.60
  • NEUE $4.30
  • Resistance Level
  • UNCY $0.65
  • NEUE $6.99
  • Average True Range (ATR)
  • UNCY 0.05
  • NEUE 0.63
  • MACD
  • UNCY -0.01
  • NEUE 0.15
  • Stochastic Oscillator
  • UNCY 3.86
  • NEUE 85.50

About UNCY Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's lead drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury.

About NEUE NEUEHEALTH INC

NeueHealth Inc is a value driven healthcare company grounded in the belief that all health consumers are entitled to high-quality, coordinated care. By uniquely aligning the interests of health consumers, providers, and payors, NeueHealth helps to make healthcare accessible and affordable to all populations across the ACA Marketplace, Medicare, and Medicaid. It also enables independent providers and medical groups to thrive in performance-based arrangements through a suite of technology and services scaled centrally and deployed locally.

Share on Social Networks: